Sjogren Syndrome Clinical Trials in São Paulo, São Paulo
2 recruitingSão Paulo, São Paulo, Brazil
Showing 1–2 of 2 trials
Recruiting
Phase 2
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
SclerodermaRheumatoid Arthritis (RA)Sjogren Syndrome+6 more
Artiva Biotherapeutics, Inc.90 enrolled52 locationsNCT06991114
Recruiting
Phase 4
TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE
Sjogren SyndromeSjogren DiseasePrimary Sjogren Syndrome
University of Sao Paulo General Hospital60 enrolled1 locationNCT07153276